International Clinical Trial: Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine)

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214285) titled 'Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine)' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University Hospital, Lille

Condition: Parkinson Disease

Intervention: Drug: A-DOPAMINE

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: October 1, 2025

Target Sample Size: 1

To know more, visit https://clinicaltrials.gov/study/NCT07214285

Published...